Journal: BMC Cancer
Article Title: Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study
doi: 10.1186/s12885-024-12827-0
Figure Lengend Snippet: Pearson’s correlation analysis between serum TFPI2 and CA125 levels. There was a low correlation between serum TFPI2 and CA125 levels ( r = 0.203, p < 0.001). CA, cancer antigen; TFPI2, tissue factor pathway inhibitor 2
Article Snippet: The other authors declare no conflicts of interest directly relevant to the content of this article.The analysis of serum TFPI2, CA125, CA19-9, and CEA levels was outsourced to the Tosoh Corporation by the Kanagawa Cancer Center.
Techniques: